Darifenacin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)
Jul 30, 2015, 09:11 ET
NEW YORK, July 30, 2015 /PRNewswire/ -- Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH 'USA VIEW'!
"The most extensive source of patent information available." Product Portfolio Manager - Dr Reddys Laboratories
"The database is reliable, frequently updated, well-arranged, user friendly." Director IP - Zentiva k.s
"Allows me to perform an analysis on an INN in hours rather than days". IP Council, top 10 generics company
Watertight, user-friendly data you can rely on
# Key patent, extension and data exclusivity expiry in one simple view
# Highly accurate, manually verified data
# Full consideration of paediatric, orphan and complex data exclusivity
# Covers over 50 countries and 1600 molecules, including over 300 biologics
Insight and understanding for all levels of expertise
# Patents interpreted and assigned to categories
# Expert constraint analysis, commentary, and SPC validity flags
# Flags indicate constraining, difficult or nuisance patents
# Available on a per molecule basis
Save vast amounts of time
# Complete, reliable and verifiable data so you don't have to fill holes and double check
# Intelligent, friendly design means fewer clicks and quicker understanding
# Hyperlinking to vital patent documentation allows fast analysis and verification
# Add your own notes, save searches and results
This report covers:
International Nonproprietary Name: Darifenacin
Indications: Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency
Innovator:Merus Labs (Emselex); Merus Labs (Enablex ); Aspen (Enablex); Warner Chilcott (Enablex)
Country Coverage:
# Albania
# Australia
# Austria
# Belgium
# Bosnia & Herzegovina
# Brazil
# Bulgaria
# Canada
# China
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Great Britain
# Greece
# Hungary
# Iceland
# Ireland
# Israel
# Italy
# Japan
# Latvia
# Lithuania
# Luxembourg
# Macedonia
# Malta
# Mexico
# Monaco
# Montenegro
# New Zealand
# Norway
# Poland
# Portugal
# Romania
# Russia
# San Marino
# Serbia
# Slovakia
# Slovenia
# South Africa
# South Korea
# Spain
# Sweden
# Switzerland
# The Netherlands
# Turkey
# USA
Please note that 9 country coverage is also available.
Access:
This report is provided through an online portal for a period of 12 months, for a maximum of 5 users. During this period, access to updates, excel exports, patent documents and national registers is provided at no additional charge.
Read the full report: http://www.reportlinker.com/p02902195-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker